SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-127141
Filing Date
2016-06-14
Accepted
2016-06-14 16:47:17
Documents
52
Period of Report
2016-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-10936_110q.htm 10-Q 794468
2 EX-31.1 a16-10936_1ex31d1.htm EX-31.1 10110
3 EX-31.2 a16-10936_1ex31d2.htm EX-31.2 10125
4 EX-32.1 a16-10936_1ex32d1.htm EX-32.1 5800
  Complete submission text file 0001104659-16-127141.txt   3581820

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bpmx-20160430.xml EX-101.INS 616854
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bpmx-20160430.xsd EX-101.SCH 32434
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bpmx-20160430_cal.xml EX-101.CAL 37679
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bpmx-20160430_def.xml EX-101.DEF 148424
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bpmx-20160430_lab.xml EX-101.LAB 297810
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bpmx-20160430_pre.xml EX-101.PRE 253367
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 161713506
SIC: 2834 Pharmaceutical Preparations